In Depth

Cell and gene therapy approvals drive paradigm change in manufacturing

After the Lykos debacle, what’s next for psychedelic therapies?

Compounding pharmacies caught in counterfeit controversy

How the Covid-19 pandemic will help researchers with the mpox emergency

Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship efforts

Clinical research in the UK must build on industry collaboration, says NIHR director

Keytruda and Opdivo: a decade review